Search results
Results from the WOW.Com Content Network
E. W. Kemble's "Death's Laboratory" on the cover of Collier's (June 3, 1905). A patent medicine, also known as a proprietary medicine or a nostrum (from the Latin nostrum remedium, or "our remedy") is a commercial product advertised to consumers as an over-the-counter medicine, generally for a variety of ailments, without regard to its actual effectiveness or the potential for harmful side ...
These patents have been broadly licensed and have been the subject of litigation among patent holders and companies that have brought monoclonal antibody drugs to market. [25] A patent application for the isolated BRCA1 gene and cancer-promoting mutations, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the ...
General Talking Pictures Corp. v. Western Electric Co. 304 U.S. 175: 1938: Upholding enforceability of field-of-use limitations in a patent license Kellogg Co. v. National Biscuit Co. 305 U.S. 111: 1938: Once a patent has expired, the benefits of the invention are to be enjoyed by the public and may not be extended by trademark.
E. W. Kemble's "Death's Laboratory" on the cover of the 3 June 1905 edition of Collier's. A patent medicine (sometimes called a proprietary medicine) is a non-prescription medicine or medicinal preparation that is typically protected and advertised by a trademark and trade name, and claimed to be effective against minor disorders and symptoms, [1] [2] [3] as opposed to a prescription drug that ...
State-of-the-Art Transdermal Drug Delivery Patents From Vyteris to be Sold via Global Online Sale by ... The global online patent sale is scheduled to launch at 10 am PT on June 27, 2013 and ...
Wikipedia entry for Google Patents.Google Patents is a search engine from Google that indexes patents and patent applications from the United States Patent and Trademark Office.
Figure 1: Five best-selling proprietary drug which lost their patents before 2017 [35] Proprietary drug is a substantial business protected by its respective patent. They are usually sold at a higher price, to compensate for the clinical trial cost and sometimes for the manufacturing of new technology. [37]
A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its weight-loss and diabetes drugs Wegovy and Ozempic brought ...